Analysis of Resistance Mmechanisms to Pralsetinib in Patients with RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC) from the ARROW Study

被引：0
|
作者：
Gainor, J. [1 ]
Curigliano, G. [2 ]
Doebele, R. C. [3 ]
Lin, J. J. [1 ]
Ou, S. -H. [4 ]
Miller, S. [5 ]
Turner, C. D. [5 ]
Subbiah, V. [6 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Univ Milan, European Inst Oncol, IRCCS, Milan, Italy
[3] Univ Colorado, Ctr Canc, Aurora, CO USA
[4] Univ Calif Irvine, Sch Med, Orange, CA 92668 USA
[5] Blueprint Medicines Corp, Cambridge, England
[6] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA05.02
引用
收藏
页码：S5 / S5
页数：1
相关论文
共 50 条
  • [1] Pralsetinib in patients with RET fusion-positive non-small cell lung cancer: A plain language summary of the ARROW study
    Griesinger, Frank
    Curigliano, Giuseppe
    Subbiah, Vivek
    Baik, Christina S.
    Tan, Daniel S. W.
    Lee, Dae H.
    Misch, Daniel
    Garralda, Elena
    Kim, Dong-Wan
    van der Wekken, Anthonie J.
    Gainor, Justin F.
    Paz-Ares, Luis
    Liu, Stephen, V
    Kalemkerian, Gregory P.
    Bowles, Daniel W.
    Mansfield, Aaron S.
    Lin, Jessica J.
    Smoljanovic, Vlatka
    Rahman, Ahmadur
    Zalutskaya, Alena
    Louie-Gao, Melinda
    Boral, Andy L.
    Mazieres, Julien
    [J]. FUTURE ONCOLOGY, 2024, 20 (06) : 297 - 306
  • [2] Pralsetinib: Treatment of metastatic RET fusion-positive non-small cell lung cancer
    Nguyen, Ly
    Monestime, Shanada
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (07) : 527 - 533
  • [3] Efficacy and safety of pralsetinib in patients with advanced RET fusion-positive non-small cell lung cancer
    Zhou, Qing
    Zhao, Jun
    Chang, Jianhua
    Wang, Huijie
    Fan, Yun
    Wang, Ke
    Wu, Gang
    Nian, Weiqi
    Sun, Yuping
    Sun, Meili
    Wang, Xiangcai
    Shi, Huaqiu
    Zheng, Xiangqian
    Yao, Sheng
    Qin, Mengmeng
    Shen, Zhenwei
    Yang, Jason
    Wu, Yi-Long
    [J]. CANCER, 2023, 129 (20) : 3239 - 3251
  • [4] Safety and efficacy of pralsetinib in patients with advanced RET fusion-positive non-small cell lung cancer: Update from the ARROW trial.
    Curigliano, Giuseppe
    Gainor, Justin F.
    Griesinger, Frank
    Thomas, Michael
    Subbiah, Vivek
    Baik, Christina S.
    Tan, Daniel Shao-Weng
    Lee, Dae Ho
    Misch, Daniel
    Garralda, Elena
    Kim, Dong-Wan
    Paz-Ares, Luis G.
    Mazieres, Julien
    Liu, Stephen V.
    Kalemkerian, Gregory Peter
    Houvras, Yariv
    Bowles, Daniel W.
    Mansfield, Aaron Scott
    Zalutskaya, Alena
    van der Wekken, Anthonie J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] Pralsetinib-associated pneumonia in RET fusion-positive non-small cell lung cancer
    Gao, Ming
    Zhang, Xia
    Yan, Huan
    Sun, Decong
    Yang, Xuejiao
    Yuan, Fang
    Ju, Yanfang
    Wang, Lijie
    Wang, Jinliang
    Zhao, Wei
    Zhang, Dong
    Li, Lin
    Xu, Xiaoyun
    Ma, Junxun
    Hu, Yi
    Zhang, Xiaotao
    [J]. SUPPORTIVE CARE IN CANCER, 2023, 31 (12)
  • [6] Pralsetinib-associated pneumonia in RET fusion-positive non-small cell lung cancer
    Ming Gao
    Xia Zhang
    Huan Yan
    Decong Sun
    Xuejiao Yang
    Fang Yuan
    Yanfang Ju
    Lijie Wang
    Jinliang Wang
    Wei Zhao
    Dong Zhang
    Lin Li
    Xiaoyun Xu
    Junxun Ma
    Yi Hu
    Xiaotao Zhang
    [J]. Supportive Care in Cancer, 2023, 31
  • [7] SORAFENIB IN PATIENTS WITH RET FUSION-POSITIVE NON-SMALL CELL LUNG CANCER
    Horiike, Atsushi
    Takeuchi, Kengo
    Uenami, Takeshi
    Kawano, Yuko
    Tanimoto, Azusa
    Kaburaki, Kyohei
    Kobayashi, Hiroshi
    Gyotoku, Hiroshi
    Nishizawa, Hironari
    Tambo, Yuichi
    Nakatomi, Katsumi
    Yanagitani, Noriko
    Ohyanagi, Fumiyoshi
    Hagiwara, Sachiko
    Motoi, Noriko
    Ishikawa, Yuichi
    Horai, Takeshi
    Nishio, Makoto
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S898 - S898
  • [8] An overview of the role of selpercatinib and pralsetinib in RET-fusion-positive non-small cell lung cancer (NSCLC)
    Nguyen, Vanessa Quang
    Geirnaert, Marc
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, : 450 - 456
  • [9] Sorafenib treatment for patients with RET fusion-positive non-small cell lung cancer
    Horiike, Atsushi
    Takeuchi, Kengo
    Uenami, Takeshi
    Kawano, Yuko
    Tanimoto, Azusa
    Kaburaki, Kyohei
    Tambo, Yuichi
    Kudo, Keita
    Yanagitani, Noriko
    Ohyanagi, Fumiyoshi
    Motoi, Noriko
    Ishikawa, Yuichi
    Horai, Takeshi
    Nishio, Makoto
    [J]. LUNG CANCER, 2016, 93 : 43 - 46
  • [10] Targeted therapy of RET fusion-positive non-small cell lung cancer
    Shen, Zixiong
    Qiu, Binxu
    Li, Lin
    Yang, Bo
    Li, Guanghu
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
12345